Connection

Yuki Kageyama to Glucocorticoids

This is a "connection" page, showing publications Yuki Kageyama has written about Glucocorticoids.
Connection Strength

0.334
  1. Role of glucocorticoid in the development of glycyrrhizin-induced hypertension. Clin Exp Hypertens. 1994 Nov; 16(6):761-78.
    View in: PubMed
    Score: 0.097
  2. Glucocorticoids suppress tumor lymphangiogenesis of prostate cancer cells. Clin Cancer Res. 2006 Oct 15; 12(20 Pt 1):6012-7.
    View in: PubMed
    Score: 0.056
  3. Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells. Clin Cancer Res. 2006 May 15; 12(10):3003-9.
    View in: PubMed
    Score: 0.054
  4. Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids. Mol Cell Endocrinol. 2004 Oct 29; 226(1-2):11-7.
    View in: PubMed
    Score: 0.049
  5. Effects of glucocorticoids on bone mineral density in rheumatoid arthritis patients. A longitudinal study. Arch Orthop Trauma Surg. 1999; 119(1-2):18-21.
    View in: PubMed
    Score: 0.032
  6. Central nervous system mediates an antihypertensive property in glucocorticoid hypertension in dogs. J Hypertens. 1995 Oct; 13(10):1169-79.
    View in: PubMed
    Score: 0.026
  7. Depressor systems contribute to hypertension induced by glucocorticoid excess in dogs. J Hypertens. 1992 Jun; 10(6):561-9.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.